key: cord-1018980-5vscj363
authors: Kimpston-Burkgren, Kay; Mora-Díaz, Juan Carlos; Roby, Philippe; Bjustrom-Kraft, Jordan; Main, Rodger; Bosse, Roger; Giménez-Lirola, Luis Gabriel
title: Characterization of the Humoral Immune Response to Porcine Epidemic Diarrhea Virus Infection under Experimental and Field Conditions Using an AlphaLISA Platform
date: 2020-03-21
journal: Pathogens
DOI: 10.3390/pathogens9030233
sha: 6d4067580f88df13b963b46bd43cbb5aecc43112
doc_id: 1018980
cord_uid: 5vscj363

Coronavirus infections are a continuous threat raised time and again. With the recent emergence of novel virulent strains, these viruses can have a large impact on human and animal health. Porcine epidemic diarrhea (PED) is considered to be a reemerging pig disease caused by the enteropathogenic alphacoronavirus PED virus (PEDV). In the absence of effective vaccines, infection prevention and control through diagnostic testing and quarantine are critical. Early detection and differential diagnosis of PEDV infections increase the chance of successful control of the disease. Therefore, there is a continuous need for development of reduced assay-step protocols, no-wash, high-throughput immunoassays. This study described the characterization of the humoral immune response against PEDV under experimental and field conditions using a rapid, sensitive, luminescent proximity homogenous assay (AlphaLISA). PEDV IgG and IgA antibodies were developed toward the beginning of the second week of infection. PEDV IgG antibodies were detected for at least 16 weeks post-exposure. Remarkably, the serum IgA levels remained high and relatively stable throughout the study, lasting longer than the serum IgG response. Overall, AlphaLISA allows the detection and characterization of pathogen-specific antibodies with new speed, sensitivity, and simplicity of use. Particularly, the bridge assay constitutes a rapid diagnostic that substantially improves upon the “time to result” metric of currently available immunoassays.

Porcine epidemic diarrhea virus (PEDV) is an alphacoronavirus, in the Coronaviridae family, of the order Nidovirales [1] that replicates in the cytoplasm of villous enterocytes of the small intestine and causes acute and watery malabsorptive diarrhea, vomiting, anorexia and dehydration in pigs [2, 3] . PEDV has an enveloped virion, containing the single-stranded, positive-sense RNA genome of~28 kb and seven open reading frames (ORFs) [4] . ORF1a and ORF1b encode the nonstructural replicase proteins required for transcription and translation. The structural proteins are encoded by the ORFs at the 3' end of the genome, including the spike protein (S), the ORF3 accessory protein, the envelope

The experimental animal study was carried out in the Iowa State University (ISU, Ames, IA, USA) Large Animal Research Facility (LAR). The study was approved by the Iowa State University Institutional Animal Care and Use Committee (5-15-8017-S) as part of a broader animal study described in detail in previous publications [23] . Briefly, twenty-four 7-week-old conventional pigs, pre-tested negative for PEDV, PDCoV, TGEV, porcine respiratory virus (PRCV) and porcine hemagglutinating encephalomyelitis virus (PHEV), were included in this study. Animals were divided into two groups (rooms) of 12 pigs each. One group was inoculated orally with 20 mL of PEDV non-S-INDEL strain (USA/IN/2013/19338E) at 1.0 × 10 6 TCID 50 . The other group (control) was inoculated with 20 mL of Eagle's minimum essential medium (EMEM, ATCC, Manassas, VA, USA). Serum samples (n = 264) were obtained from individual pigs at −7, 0, 3, 7, 10, 14, 17, 21, 28, 35 , and 42 (euthanasia) days post-inoculation (dpi).

The field animal study was carried out in a commercial wean-to-finish barn in Missouri (USA), which consisted of 52 pens stocked with approximately 800 pigs placed at 3 weeks of age as previously described [24] . Six pens were selected (fixed) for serial sample collection. Five pig serum samples were collected from the same 6 pens starting at the day of placement, weekly for 6 weeks and biweekly thereafter for 19 weeks giving a total of 360 samples. Pigs were exposed to PEDV at 10 days post-placement (13- week-old) using water-mixed PEDV-positive material sprayed oronasally on pigs and feed.

A recombinant S1 glycoprotein was generated as described by Gimenez-Lirola et al. [23] . A consensus sequence of the amino-terminal S1 domain of the spike protein was generated from PEDV non-S-INDEL strains. The sequence was codon optimized for expression in mammalian cells. A 5' terminal eukaryotic native signal was followed by a 3' terminal tobacco etch virus cysteine protease site with a human IgG1 Fc portion tag. Genes were amplified then cloned in the pNPM5 expression vector (Novoprotein, Short Hills, NJ, USA), which was used to transfect into human embryonic kidney 293 (HEK293) cells (Invitrogen, Thermo Fisher Scientific, Grand Island, NY, USA) by polyethylenimine (PEI) treatment at a 1:4 plasmid to PEI ratio. Transfected cells were grown in serum free FreeStyle 293 expression medium (Gibco, Life Technologies, Carlsbad, CA, USA) at 37 • C with 5% CO 2 and orbital shaking at 120 rpm. Five days after transfection, culture supernatants were harvested and filtered for subsequent purification. The expression of Fc tagged S1 protein was confirmed by sodium dodecyl sulfate polyacrylamide gel (12%) electrophoresis (SDS-PAGE). The Fc portion was then cleaved off and the S1 portion was purified by protein A chromatography and nickel-chelating Sepharose Fast Flow affinity chromatography (GE Healthcare, Pittsburgh, PA, USA) according to manufacturer instructions. Purified S1 protein (717 amino acids) was then dialyzed against phosphate buffered saline (PBS) pH 7.4, and analyzed by SDS-PAGE and Western blotting.

The S1 protein was conjugated to raw (aldehyde) AlphaLISA Acceptor and Donor beads via reductive amination and according to manufacturer's protocol (PerkinElmer Health Sciences, Inc., Boston, MA, USA). Briefly, 0.1 mg of S1 protein (1 mg/mL) was mixed with 1 mg AlphaLISA beads in a 2 mL vial (Eppendorf, Hauppauge, NY, USA) and completed with reaction buffer (100 mM HEPES pH 7.4) to a final reaction volume of 200 µL. Then, 1.25 µL of 10% Tween-20 (Sigma, St. Louis, MO, USA) and 10 µL of a 400 mM solution of the reducing agent sodium cyanoborohydride (NaBH3CN; Sigma) were added to the 2 mL vial and the reaction mix was incubated for 18-24 h at 37 • C with mild agitation (6-10 rpm) using a rotary shaker. Unreacted aldehyde groups on beads were blocked by adding 10 µL solution of carboxymethoxylamine (CMO, Sigma) at 65 mg/mL in 800 mM sodium hydroxide (NaOH, Sigma) followed by a 60 min incubation at 37 • C under mild agitation. The uncoupled S1 protein was removed by centrifugation (16,000× g for 15 min at 4 • C) and washing the beads three times. Supernatant was removed with a micropipette and the bead pellet resuspended in 200 µL of 100 mM Tris-HCl pH 8.0. The bead solution was briefly sonicated in a sonicating water bath (Branson Ultrasonic Corp., Danbury, CT, USA) to ensure that the beads are not aggregated. After the last centrifugation, beads were resuspended at 5 mg/mL in storage buffer (200 µL of PBS + 0.05% Proclin-300 as a preservative), re-sonicated and stored at 4 • C until use.

This AlphaLISA procedure was designed as a 2 h, two-step, no-wash, isotype-specific (IgG, IgA) immunoassay, where PEDV IgG and/or IgA antibody could be detected simultaneously, in two separate wells, within the same plate ( Figure 1A ). Incubations were performed in half area 96-well white plates (PerkinElmer) at room temperature (~22 • C), protected from light, and on a rotating shaker. In the first step either 5 µL of serum sample or control, pre-diluted 1:100 in PBS pH 7.4 (Gibco, Thermo Scientific), was incubated for 1 h with 20 µL of a mix containing 25 µg/mL of S1 protein-conjugated AlphaLISA Acceptor beads and 7.5 nM biotinylated goat anti-pig IgG (Fc) or 5 nM biotinylated goat anti-pig IgA (Bethyl Laboratories Inc., Montgomery, TX, USA) in assay buffer 1x (AlphaLISA Assay Buffer 10X; PerkinElmer). Then, in a second step, 25 µL of 80 µg/mL Streptavidin Donor beads (PerkinElmer) were directly added to each well and incubated for 1 h in a final reaction volume of 50 µL per well.

In the presence of PEDV-specific IgG and/or IgA antibodies, Acceptor and Donor beads come into close proximity. Laser irradiation of Donor beads at 680 nm caused the release of singlet oxygen molecules that triggered a cascade of chemical events in nearby Acceptor beads, which resulted in a sharp peak in chemiluminescent emission at 615 nm that was read in an EnVision ® multimode plate reader (PerkinElmer) ( Figure S1 ). AlphaLISA results were converted into sample-to-positive ratios on the basis of the positive and negative internal controls.

Pathogens 2020, 9, x FOR PEER REVIEW 4 of 10 (AlphaLISA Assay Buffer 10X; PerkinElmer). Then, in a second step, 25 µl of 80 µg/ml Streptavidin Donor beads (PerkinElmer) were directly added to each well and incubated for 1 h in a final reaction volume of 50 µl per well. In the presence of PEDV-specific IgG and/or IgA antibodies, Acceptor and Donor beads come into close proximity. Laser irradiation of Donor beads at 680 nm caused the release of singlet oxygen molecules that triggered a cascade of chemical events in nearby Acceptor beads, which resulted in a sharp peak in chemiluminescent emission at 615 nm that was read in an EnVision ® multimode plate reader (PerkinElmer) ( Figure S1 ). AlphaLISA results were converted into sampleto-positive ratios on the basis of the positive and negative internal controls. 

This AlphaLISA bridge assay was designed as an antigen sandwich immunoassay for rapid detection (5 to 60 min, 1-step) of the total antibodies specific for PEDV ( Figure 1B ). In brief, 5 µl of undiluted serum samples or controls were incubated with 45 µl of bead mix containing 20 µg/ml of both S1-coupled Donor and S1-coupled Acceptor beads in assay buffer for 5, 30 or 60 min at room temperature (~22 ℃), preserved from light, and on a rotating shaker. Results were obtained and processed as previously described for the isotype-specific assay.

To assess the differences in the PEDV antibody responses between experimentally inoculated PEDV vs. control groups, a generalized linear model with mixed effects (PROC GLIMMIX) was performed for IgG and IgA separately. Treatments (PEDV vs. medium inoculation) and dpi were fixed effects, while the pigs were the random effect due to the repeated measurements on the same animals. A p-value < 0.05 was considered statistically significant. Pearson correlation analysis between the IgG and IgA response (daily average of AlphaLISA S/P values) in PEDV inoculated pigs 

This AlphaLISA bridge assay was designed as an antigen sandwich immunoassay for rapid detection (5 to 60 min, 1-step) of the total antibodies specific for PEDV ( Figure 1B ). In brief, 5 µL of undiluted serum samples or controls were incubated with 45 µL of bead mix containing 20 µg/mL of both S1-coupled Donor and S1-coupled Acceptor beads in assay buffer for 5, 30 or 60 min at room temperature (~22 • C), preserved from light, and on a rotating shaker. Results were obtained and processed as previously described for the isotype-specific assay.

To assess the differences in the PEDV antibody responses between experimentally inoculated PEDV vs. control groups, a generalized linear model with mixed effects (PROC GLIMMIX) was performed for IgG and IgA separately. Treatments (PEDV vs. medium inoculation) and dpi were fixed effects, while the pigs were the random effect due to the repeated measurements on the same animals. A p-value < 0.05 was considered statistically significant. Pearson correlation analysis between the IgG and IgA response (daily average of AlphaLISA S/P values) in PEDV inoculated pigs was performed by dividing the experimental study (49 days) into three periods: −7 to 3 dpi, 7 to 17 dpi, and 21 to 42 dpi. To determine the difference in S/P values among the three incubation periods for the PEDV inoculated group, a GLIMMIX model was used with incubation time and dpi as the fixed effects and the pigs as the random effect.

The PEDV isotype-specific (IgG and IgA) antibody response under field conditions was evaluated using a GLIMMIX model, where antibody isotype and week post-exposure (wpe) were the fixed effects, and the pigs were the random effect. Pearson correlation analysis between the IgG and IgA responses (weekly average of AlphaLISA S/P values) in PEDV inoculated pigs was performed by dividing the field animal study (19 weeks) into three periods: −2 to 1 wpe, 2 to 8 wpe, and 10 to 16 wpe.

Optimal cutoff values and diagnostic performance of the PEDV AlphaLISA platform were estimated by receiver operating characteristic curve (ROC) analysis. All statistical analyses were performed using SAS version 9.4 (SAS, Cary, North Carolina/USA, SAS Institute, Inc.).

A ROC analysis was performed for both AlphaLISA IgG and IgA assay. Selected S/P cutoff values were 0.25 for IgG and 0.15 for IgA. The PEDV antibody-positive detection rates per day post-inoculation or exposure under experimental or field conditions are presented in Table 1 or Table 2 , respectively. The overall diagnostic specificity, calculated by using over 257 negative serum samples, was 99.2% for IgG and 100% for IgA. 

Pigs in the negative control group remained IgG/IgA seronegative throughout the study. PEDV-inoculated pigs developed a detectable IgG antibody response by 10 dpi. The IgG response increased overtime, reaching a plateau by dpi 35. PEDV IgG response was statistically significant (p < 0.05), compared to the negative control group, from dpi 14 until the end of the study (Figure 2A) . Although PEDV IgA response was first detected by 7 dpi (Table 1) , the average IgA response was statistically significant (p < 0.05) compared to the negative group from dpi 10 to 42. The IgA S/P ratios increased until 14 dpi, decreased slightly at 17 and 21 dpi, and continued to rise until the end of the study. ( Figure 2B) .

Overall, the IgG and IgA S/P values were positively correlated (0.89) throughout the experimental study. Specifically, the correlation for the first period (dpi −7 to 3) was 0.96, 0.64 for the second period (dpi 7 to 17), and 0.97 for the third period (dpi 21 to 42).

The isotype specific antibody response to PEDV exposure under field conditions is presented in Figure 3 . PEDV IgG and IgA antibodies were detected between 1-2 weeks post-exposure. IgG response decreased consistently thereafter, while the IgA response peaked ~8 weeks post-exposure and remained fairly stable until the end of the study. Although PEDV IgA response was first detected by 7 dpi (Table 1) , the average IgA response was statistically significant (p < 0.05) compared to the negative group from dpi 10 to 42. The IgA S/P ratios increased until 14 dpi, decreased slightly at 17 and 21 dpi, and continued to rise until the end of the study. ( Figure 2B) .

Overall, the IgG and IgA S/P values were positively correlated (0.89) throughout the experimental study. Specifically, the correlation for the first period (dpi −7 to 3) was 0.96, 0.64 for the second period (dpi 7 to 17), and 0.97 for the third period (dpi 21 to 42).

The isotype specific antibody response to PEDV exposure under field conditions is presented in Figure 3 . PEDV IgG and IgA antibodies were detected between 1-2 weeks post-exposure. IgG response decreased consistently thereafter, while the IgA response peaked~8 weeks post-exposure and remained fairly stable until the end of the study. (19 weeks) in pigs (n = 30) exposed to PEDV under field conditions. *Denoted statistical differences (p < 0.05).

Overall, correlation analysis comparing IgG and IgA responses under field conditions showed a low positive correlation (0.67) over time. A weak positive correlation was observed for the first (−2 to 1 wpe; 0.62) and third (10 to 16 wpe; 0.40) periods. Contrary, a negative correlation between IgG and IgA antibody response (opposite trend) was observed for the second period (2 to 8 wpe; 0.92).

The PEDV total antibody bridging rapid assay was evaluated on the experimental samples. Antibody response at three different incubation periods were compared: 5, 30, and 60 min. PEDV antibody response was detected, and peaked, at 7 dpi, decreased until 17 dpi, being stable thereafter ( Figure 4) . No antibody response was detected in the negative control group. No significant differences (p > 0.05) on total antibody S/P values were found, regardless of incubation time. (5, 30 , and 60 min) on serum samples from pigs (n = 12) experimentally inoculated with PEDV or mock inoculated (n = 12) with culture medium using AlphaLISA bridging rapid assay.

The emergence of highly virulent PEDV strains in the United States in 2013 fostered the development of a greater number of diagnostic tools broadly described through the literature. While PEDV RNA detection in fecal specimens is used to confirm presence of PEDV during outbreaks of severe diarrhea in neonatal pigs with high mortality, serology tests are important for surveillance, Negative control (60 minutes) Figure 3 . AlphaLISA PEDV isotype-specific (IgG/IgA) antibody responses (mean S/P values, SE) over time (19 weeks) in pigs (n = 30) exposed to PEDV under field conditions. *Denoted statistical differences (p < 0.05).

Overall, correlation analysis comparing IgG and IgA responses under field conditions showed a low positive correlation (0.67) over time. A weak positive correlation was observed for the first (−2 to 1 wpe; 0.62) and third (10 to 16 wpe; 0.40) periods. Contrary, a negative correlation between IgG and IgA antibody response (opposite trend) was observed for the second period (2 to 8 wpe; 0.92).

The PEDV total antibody bridging rapid assay was evaluated on the experimental samples. Antibody response at three different incubation periods were compared: 5, 30, and 60 min. PEDV antibody response was detected, and peaked, at 7 dpi, decreased until 17 dpi, being stable thereafter ( Figure 4) . No antibody response was detected in the negative control group. No significant differences (p > 0.05) on total antibody S/P values were found, regardless of incubation time.

Pathogens 2020, 9, x FOR PEER REVIEW 7 of 10 Figure 3 . AlphaLISA PEDV isotype-specific (IgG/IgA) antibody responses (mean S/P values, SE) over time (19 weeks) in pigs (n = 30) exposed to PEDV under field conditions. *Denoted statistical differences (p < 0.05).

Overall, correlation analysis comparing IgG and IgA responses under field conditions showed a low positive correlation (0.67) over time. A weak positive correlation was observed for the first (−2 to 1 wpe; 0.62) and third (10 to 16 wpe; 0.40) periods. Contrary, a negative correlation between IgG and IgA antibody response (opposite trend) was observed for the second period (2 to 8 wpe; 0.92).

The PEDV total antibody bridging rapid assay was evaluated on the experimental samples. Antibody response at three different incubation periods were compared: 5, 30, and 60 min. PEDV antibody response was detected, and peaked, at 7 dpi, decreased until 17 dpi, being stable thereafter ( Figure 4 ). No antibody response was detected in the negative control group. No significant differences (p > 0.05) on total antibody S/P values were found, regardless of incubation time. (5, 30 , and 60 min) on serum samples from pigs (n = 12) experimentally inoculated with PEDV or mock inoculated (n = 12) with culture medium using AlphaLISA bridging rapid assay.

The emergence of highly virulent PEDV strains in the United States in 2013 fostered the development of a greater number of diagnostic tools broadly described through the literature. While PEDV RNA detection in fecal specimens is used to confirm presence of PEDV during outbreaks of severe diarrhea in neonatal pigs with high mortality, serology tests are important for surveillance, . Rapid detection of PEDV total antibodies (average S/P, SE) at different incubation times (5, 30 , and 60 min) on serum samples from pigs (n = 12) experimentally inoculated with PEDV or mock inoculated (n = 12) with culture medium using AlphaLISA bridging rapid assay.

The emergence of highly virulent PEDV strains in the United States in 2013 fostered the development of a greater number of diagnostic tools broadly described through the literature. While PEDV RNA detection in fecal specimens is used to confirm presence of PEDV during outbreaks of severe diarrhea in neonatal pigs with high mortality, serology tests are important for surveillance, detection of asymptomatic or mild cases, monitoring response to immunization strategies, and demonstrating previous exposure to the virus. However, there is a continuous need for development of reduced assay-steps protocols and no-wash immunoassays allowing to run more samples in a shorter period of time. Thereby, the recent development of bead-based methods and microfluidic platforms like AlphaLISA have started to impact immunoassays, taking the sensitivity of traditional enzyme immunoassays to the next level.

A recombinant protein derived of the amino-terminal portion (S1) of the PEDV spike protein was used as an antigen for the development of the AlphaLISA immunoassay platforms described herein. In brief, the homotrimeric S glycoprotein, class I fusion protein essential for both host specificity and viral infectivity, is the main driver of the neutralizing antibody and T-cell immune responses against PEDV and a major immunogenic target for vaccine design [25] [26] [27] . Similar to other coronaviruses, PEDV S protein is composed of two subunits; the highly variable S1 subunit (N-terminal) contains receptor-binding domain(s), which remains unknown, responsible for viral attachment and the conserved S2 subunit (C-terminal) which mediates fusion between the viral and host cell membranes, and contains immunodominant neutralizing epitopes [28, 29] . The selected S1 region is characterized by multiple amino acid insertions, deletions, and substitutions [30] , that allow for a differential serodiagnosis of PEDV and rule out cross-reactivity against other porcine coronaviruses that might be cocirculating in swine herds [23] . However, S1 may not recognize some neutralizing antibodies specifically directed against S2 [29] . Although structural proteins N and M are highly antigenic, they are also one of the most conserved and, therefore, cross-reactive proteins among coronaviruses [23] .

There is a need for research and development to translate new technologies into practical tests. Therefore, the aim of the study was to characterize the humoral response to oral exposure to PEDV non S-INDEL strain, currently circulating in North America, under controlled (i.e., time to exposure to PEDV) experimental (livestock-infectious disease BSL-2 isolation facility) and field (wean-to-finish commercial farm) conditions, respectively. To achieve this objective, a homogeneous (no washing steps required) 2 h and two-steps AlphaLISA IgG/IgA assay platform was used. Experimental serum samples were previously tested by IgG ELISA and multiplex Luminex platform [24] , while field serum samples were previously tested by IgG/IgA ELISA [23] . Like in these previous studies, PEDV IgG and IgA specific antibodies were detected by AlphaLISA toward the beginning of the second week of infection, regardless of exposure conditions. Longitudinal field study allowed further assessment of the duration of IgG and IgA antibody response in a serum. In concordance with our previous study [24] , PEDV IgG antibodies were detected for at least 16 wpe by AlphaLISA, showing a similar downward trend than that obtained by ELISA. However, the AlphaLISA serum IgA levels remained high and relatively stable throughout the study lasting longer than the IgA levels previously reported by ELISA. Unexpectedly and contrary to the serum antibody profile obtained by ELISA, we reported a strong long-lasting AlphaLISA IgA response compared to the AlphaLISA IgG response. This study demonstrates that isotype antibody detection would depend on the analytical sensitivity and dynamic range of the immunoassay platform used.

Overall AlphaLISA enables the detection and characterization of pathogen-specific antibodies with new speed, sensitivity, and simplicity of use. Particularly, the bridge assay constitutes a rapid diagnostic that substantially improves upon the "time to result" metric of currently available immunoassays.

Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/3/233/s1, Figure S1 : Overall principle of the AlphaLISA assay technology, and image of the EnVision®2105 multimode microplate reader used in this study. 

Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses

Experimental infection of pigs with a new porcine enteric coronavirus, CV 777

Pathogenesis of porcine epidemic diarrhea virus isolate (US/Iowa/18984/2013) in 3-week-old weaned pigs

Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence

Leter to the editor. Pig Farm

An apparently new syndrome of porcine epidemic diarrhoea

Virus-like particles associated with porcine epidemic diarrhoea

A new coronavirus-like particle associated with diarrhea in swine

An outbreak of swine diarrhea of a new-type associated with coronavirus-like particles in Japan

Study on the culture of porcine epidemic diarrhea virus adapted to fetal porcine intestine primary cell monolayer

Isolation of porcine epidemic diarrhea virus (PEDV) infection in Korea

Investigation on epidemic diarrhea in pigs in Qinghai region

Outbreak of porcine epidemic diarrhea in suckling piglets

Emergence of Porcine epidemic diarrhea virus in the United States: Clinical signs, lesions, and viral genomic sequences

Scientific Opinion on porcine epidemic diarrhoea and emerging pig deltacoronavirus

Isolation of porcine epidemic diarrhea virus in porcine cell cultures and experimental infection of pigs of different ages

From the field to the lab-An European view on the global spread of PEDV

Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains

Distinct characteristics and complex evolution of PEDV strains

Pathogenesis comparison between the United States porcine epidemic diarrhoea virus prototype and S-INDEL-variant strains in conventional neonatal piglets

Porcine epidemic diarrhea virus: An overview of current virological and serological diagnostic methods

Luminescent oxygen channeling assay (LOCI): Sensitive, broadly applicable homogeneous immunoassay method

Reactivity of Porcine Epidemic Diarrhea Virus Structural Proteins to Antibodies against Porcine Enteric Coronaviruses: Diagnostic Implications

Porcine epidemic diarrhea virus (PEDV) detection and antibody response in commercial growing pigs

Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies

Efficient priming of CD4 T cells by Langerin-expressing dendritic cells targeted with porcine epidemic diarrhea virus spike protein domains in pigs

Development of an indirect ELISA, blocking ELISA, fluorescent microsphere immunoassay and fluorescent focus neutralization assay for serologic evaluation of exposure to North American strains of Porcine Epidemic Diarrhea Virus

The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex

The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes

Porcine epidemic diarrhea virus: An emerging and re-emerging epizootic swine virus

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license

Funding: This research received no external funding.

The authors declare no conflicts of interest with respect to the research authorship, and/or publication of this article.